Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.20.2
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Earnings Per Share


The following table presents computations of basic and diluted earnings per share under the two-class method:

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) attributable to Cinemark Holdings, Inc.

 

$

(147,592

)

 

$

31,353

 

 

$

(377,572

)

 

$

165,052

 

Loss (earnings) allocated to participating share-based awards (1)

 

 

1,472

 

 

 

(211

)

 

 

2,832

 

 

 

(1,012

)

Net income (loss) attributable to common stockholders

 

$

(146,120

)

 

$

31,142

 

 

$

(374,740

)

 

$

164,040

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator (shares in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common stock outstanding

 

 

116,707

 

 

 

116,356

 

 

 

116,552

 

 

 

116,288

 

Common equivalent shares for restricted stock units (2)

 

 

 

 

 

244

 

 

 

 

 

 

289

 

Diluted common equivalent shares

 

 

116,707

 

 

 

116,600

 

 

 

116,552

 

 

 

116,577

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per share attributable to common stockholders

 

$

(1.25

)

 

$

0.27

 

 

$

(3.22

)

 

$

1.41

 

Diluted earnings (loss) per share attributable to common stockholders

 

$

(1.25

)

 

$

0.27

 

 

$

(3.22

)

 

$

1.41

 

 

 

(1)

For the three months ended September 30, 2020 and 2019, a weighted average of approximately 1,175 and 793 shares of restricted stock, respectively, were considered participating securities.  For the nine months ended September 30, 2020 and 2019, a weighted average of approximately 880 and 719 shares of restricted stock, respectively, were considered participating securities.  

 

(2)

For the three months ended September 30, 2020, approximately 438 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.  For the nine months ended September 30, 2020, approximately 689 common equivalent shares for restricted stock units were excluded because they were anti-dilutive.